India approves its first dengue vaccine, from Japan's Takeda

PharmaceuticalsSouth Asian country grapples with sharp rise in cases over recent yearsThe number of dengue cases in India has soared elevenfold over the past two decades, according to Takeda Pharmaceutical. © ReutersTAKANORI OKABEJuly 21, 2026 23:00 JSTMUMBAI -- Indian regulators have approved Japanese drugmaker Takeda Pharmaceutical's vaccine against dengue, the country's first such vaccine, in a bid to curb the increasingly rapid spread of the disease.